Literature DB >> 26291882

iRhoms in the brain - a new frontier?

Stefan F Lichtenthaler1,2,3,4, Bruce F O'Hara5, Carl P Blobel4,6,7.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 26291882      PMCID： PMC4825628          DOI： 10.1080/15384101.2015.1084187

Source DB:  PubMed          Journal:  Cell Cycle        ISSN： 1551-4005            Impact factor:   4.534


× No keyword cloud information.
  7 in total

1.  Regulation of daily locomotor activity and sleep by hypothalamic EGF receptor signaling.

Authors:  A Kramer; F C Yang; P Snodgrass; X Li; T E Scammell; F C Davis; C J Weitz
Journal:  Science       Date:  2001-12-21       Impact factor: 47.728

Review 2.  Immune attack: the role of inflammation in Alzheimer disease.

Authors:  Frank L Heppner; Richard M Ransohoff; Burkhard Becher
Journal:  Nat Rev Neurosci       Date:  2015-06       Impact factor: 34.870

3.  iRhoms 1 and 2 are essential upstream regulators of ADAM17-dependent EGFR signaling.

Authors:  Xue Li; Thorsten Maretzky; Gisela Weskamp; Sébastien Monette; Xiaoping Qing; Priya Darshinee A Issuree; Howard C Crawford; David R McIlwain; Tak W Mak; Jane E Salmon; Carl P Blobel
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-27       Impact factor: 11.205

4.  Rhomboid family pseudoproteases use the ER quality control machinery to regulate intercellular signaling.

Authors:  Markus Zettl; Colin Adrain; Kvido Strisovsky; Viorica Lastun; Matthew Freeman
Journal:  Cell       Date:  2011-04-01       Impact factor: 41.582

Review 5.  Inflammation-sleep interface in brain disease: TNF, insulin, orexin.

Authors:  Ian A Clark; Bryce Vissel
Journal:  J Neuroinflammation       Date:  2014-03-21       Impact factor: 8.322

6.  Alzheimer's disease: early alterations in brain DNA methylation at ANK1, BIN1, RHBDF2 and other loci.

Authors:  Philip L De Jager; Gyan Srivastava; Katie Lunnon; Jeremy Burgess; Leonard C Schalkwyk; Lei Yu; Matthew L Eaton; Brendan T Keenan; Jason Ernst; Cristin McCabe; Anna Tang; Towfique Raj; Joseph Replogle; Wendy Brodeur; Stacey Gabriel; High S Chai; Curtis Younkin; Steven G Younkin; Fanggeng Zou; Moshe Szyf; Charles B Epstein; Julie A Schneider; Bradley E Bernstein; Alex Meissner; Nilufer Ertekin-Taner; Lori B Chibnik; Manolis Kellis; Jonathan Mill; David A Bennett
Journal:  Nat Neurosci       Date:  2014-08-17       Impact factor: 24.884

Review 7.  Divergent roles for tumor necrosis factor-alpha in the brain.

Authors:  Krishnan Sriram; James P O'Callaghan
Journal:  J Neuroimmune Pharmacol       Date:  2007-03-31       Impact factor: 7.285
  7 in total
  3 in total

1.  The molecular, cellular and pathophysiological roles of iRhom pseudoproteases.

Authors:  Iqbal Dulloo; Sonia Muliyil; Matthew Freeman
Journal:  Open Biol       Date:  2019-03-29       Impact factor: 6.411

Review 2.  Strategies to Target ADAM17 in Disease: From its Discovery to the iRhom Revolution.

Authors:  Matteo Calligaris; Doretta Cuffaro; Simone Bonelli; Donatella Pia Spanò; Armando Rossello; Elisa Nuti; Simone Dario Scilabra
Journal:  Molecules       Date:  2021-02-10       Impact factor: 4.411

Review 3.  iRhom2: An Emerging Adaptor Regulating Immunity and Disease.

Authors:  Mazin A Al-Salihi; Philipp A Lang
Journal:  Int J Mol Sci       Date:  2020-09-08       Impact factor: 5.923
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.